ZA974912B - Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenyl-propionate. - Google Patents

Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenyl-propionate.

Info

Publication number
ZA974912B
ZA974912B ZA9704912A ZA974912A ZA974912B ZA 974912 B ZA974912 B ZA 974912B ZA 9704912 A ZA9704912 A ZA 9704912A ZA 974912 A ZA974912 A ZA 974912A ZA 974912 B ZA974912 B ZA 974912B
Authority
ZA
South Africa
Prior art keywords
phenyl
methyl
imidazolidin
acetylamino
dioxo
Prior art date
Application number
ZA9704912A
Other languages
English (en)
Inventor
Hans Ulrich Stilz
Gerhard Beck
Manfred Radau
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA974912B publication Critical patent/ZA974912B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA9704912A 1996-06-05 1997-06-04 Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenyl-propionate. ZA974912B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19622489A DE19622489A1 (de) 1996-06-05 1996-06-05 Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters

Publications (1)

Publication Number Publication Date
ZA974912B true ZA974912B (en) 1997-12-05

Family

ID=7796165

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704912A ZA974912B (en) 1996-06-05 1997-06-04 Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenyl-propionate.

Country Status (24)

Country Link
US (1) US6294562B1 (no)
EP (1) EP0811616B1 (no)
JP (1) JP4249277B2 (no)
KR (1) KR980002029A (no)
CN (1) CN1104420C (no)
AR (1) AR008993A1 (no)
AT (1) ATE294783T1 (no)
AU (1) AU717106B2 (no)
BR (1) BR9703459A (no)
CA (1) CA2206748C (no)
CZ (1) CZ292672B6 (no)
DE (2) DE19622489A1 (no)
ES (1) ES2241016T3 (no)
HK (1) HK1006359A1 (no)
HR (1) HRP970309B1 (no)
HU (1) HUP9700998A3 (no)
IL (1) IL120984A (no)
MX (1) MX9704128A (no)
NO (1) NO307999B1 (no)
PL (1) PL320355A1 (no)
RU (1) RU2174119C2 (no)
SK (1) SK70897A3 (no)
TR (1) TR199700457A2 (no)
ZA (1) ZA974912B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19647380A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
RU2319702C2 (ru) * 2003-10-02 2008-03-20 Фармация Энд Апджон Компани Ллс Негигроскопическая кристаллическая малеатная соль 5-[(z)-(5-фтор-2-оксо-1,2-дигидро-3h-индол-3-илиден)метил]-n-[(2s)-2-гидрокси-3-морфолин-4-илпропил]-2,4-диметил-1h-пиррол-3-карбоксамида, фармацевтическая композиция и способ лечения рака
US20090298814A1 (en) * 2005-06-07 2009-12-03 Ramot At Tel Aviv Univeristy Ltd Novel salts of conjugated psychotropic drugs and processes of preparing same
AU2007274583B2 (en) 2006-07-17 2012-11-01 Bar-Ilan University Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders
WO2009101616A1 (en) 2008-02-11 2009-08-20 Ramot At Tel Aviv University Ltd. Novel conjugates for treating neurodegenerative diseases and disorders
AU2010329440A1 (en) 2009-12-09 2012-08-09 Bar-Ilan University Methods of improving cognitive functions
EP2539857A4 (en) 2010-02-24 2013-07-24 Univ Ramot CRYSTALLINE FORMS OF PERPHENAZINE GABA TRIMESYLATE SALT AND PROCESS FOR PRODUCTION THEREOF
WO2012038963A1 (en) 2010-09-22 2012-03-29 Ramot At Tel-Aviv University Ltd. An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
AR114489A1 (es) * 2018-04-12 2020-09-09 Morphic Therapeutic Inc ANTAGONISTAS DE LA INTEGRINA a4b7 HUMANA
JP7437495B2 (ja) 2019-10-16 2024-02-22 モーフィック セラピューティック，インコーポレイテッド ヒトインテグリンα４β７の阻害

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
DE4213634A1 (de) * 1992-04-24 1993-10-28 Cassella Ag 2,4-Dioxo-imidazolidin-Derivate
DE4224414A1 (de) 1992-07-24 1994-01-27 Cassella Ag Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung
DE4308034A1 (de) 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4309867A1 (de) 1993-03-26 1994-09-29 Cassella Ag Neue Harnstoffderivate, ihre Herstellung und Verwendung
DE4427979A1 (de) 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
DE19515177A1 (de) * 1995-04-28 1996-10-31 Cassella Ag Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe

Also Published As

Publication number Publication date
NO972506D0 (no) 1997-06-02
HUP9700998A3 (en) 1999-03-01
HRP970309B1 (en) 2002-06-30
HK1006359A1 (en) 1999-02-26
MX9704128A (es) 1997-12-31
ES2241016T3 (es) 2005-10-16
PL320355A1 (en) 1997-12-08
NO972506L (no) 1997-12-08
TR199700457A2 (xx) 1997-12-21
EP0811616B1 (de) 2005-05-04
NO307999B1 (no) 2000-07-03
HRP970309A2 (en) 1998-04-30
ATE294783T1 (de) 2005-05-15
DE59712294D1 (de) 2005-06-09
BR9703459A (pt) 1998-10-06
CA2206748A1 (en) 1997-12-05
US6294562B1 (en) 2001-09-25
CZ172997A3 (en) 1997-12-17
SK70897A3 (en) 1999-05-07
CN1174835A (zh) 1998-03-04
RU2174119C2 (ru) 2001-09-27
AU2467497A (en) 1997-12-11
DE19622489A1 (de) 1997-12-11
JP4249277B2 (ja) 2009-04-02
IL120984A (en) 2001-08-26
KR980002029A (ko) 1998-03-30
HU9700998D0 (en) 1997-07-28
EP0811616A1 (de) 1997-12-10
HUP9700998A1 (hu) 1998-03-30
AU717106B2 (en) 2000-03-16
IL120984A0 (en) 1997-11-20
JPH1059948A (ja) 1998-03-03
CA2206748C (en) 2007-05-01
AR008993A1 (es) 2000-03-08
CN1104420C (zh) 2003-04-02
CZ292672B6 (cs) 2003-11-12

Similar Documents

Publication Publication Date Title
EG24401A (en) Mesylate. Trihydrate of. 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-ine
AU656344B2 (en) N-(4-(5-(cyclopentyloxycarbonyl)-amino-1-methyl-indol- 3-ylmethyl)-3 methoxybenzoyl)-2-methylbenzene-sulphonamide
DZ2222A1 (fr) Dihydrates de mésylate de 5-(2-(4-(1,2-benzisothiazole-3-al)-1-pipérazinyl)éthyl)-6-chloro-1,3-dihydro-2h-indole-2-one.
IL143868A0 (en) Use of 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5-tetramethylene -delta 3-dihydrofurane-2-on for controlling the white fly
ZA974912B (en) Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)acetylamino)-3-phenyl-propionate.
GB9515412D0 (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
ZA972973B (en) Substituted [2-(1-piperazinyl)ethoxy]methyl compounds.
AU1131800A (en) 3-(substituted phenyl)-5-(substituted heterocyclyl)-1,2,4-triazole compounds
IL148273A0 (en) Glucopyranoside conijugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols
ZA9811490B (en) Herbicidal 3-(benzazol-4-yl)pyrimidinedione derivatives.
AU1063497A (en) 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives
AU4436296A (en) 6-{triazolyl{3-(trifluoromethyl)phenyl}methyl}-2- quinolinones and -quinolinethiones
PL344994A1 (en) Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems
IL138307A0 (en) PROCESSES FOR THE PREPARATION OF (R)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL) ETHYL]-4-PIPERIDINEMETHANOL
AU1527297A (en) Herbicidal 3-(substituted-benzyl)-1-methyl-6-trifluoromethyluracils
IL125453A0 (en) 4-(Benzo-1,3-dioxylyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
AU4625199A (en) Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used
IL129647A0 (en) Substituted 4-(6-fluoro-(1H)-indol-3-YL)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders
NZ301453A (en) 4-(substituted phenyl),4-(substituted carboxyl, carboxylamide or alkyl)-cyclohexan-1-one derivatives and medicaments
ZA969927B (en) 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives.
AU2669001A (en) Cyclopropyl-anellated 3-(4,5-dihydroisoxazol-3-yl)-substitued benzoylpyrazoles
ZA99549B (en) 2-(2'-hydroxyphenyl) benzotriazoles containing A 2,4-Imidazolidinedione group and process for their preparation.
EP0699675A3 (en) 3- (4- (1-Substituted-4-piperazinyl) butyl) -4-thiazolidinone and related compounds
ZA991907B (en) Novel processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol.
ZA989842B (en) Esters of (+)-Ó-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol.